Recent Acquisitions Trudell Medical International has recently acquired assets from Vyaire Medical and InCarda Therapeutics, showcasing a focus on expanding its product portfolio. This presents a potential sales opportunity to introduce complementary respiratory medical devices to existing and new clients.

Increased Headcount With a 60-worker increase and addition of a third shift to meet COVID-19 related demand, Trudell Medical International is likely scaling up production. This surge in capacity provides a window for sales of its aerosol drug delivery and lung health devices, especially during the current health crisis.

Cutting-Edge Technology Utilizing technologies like Microsoft Azure and PWA, Trudell Medical International demonstrates a commitment to innovation. Highlighting these advanced tech solutions in sales pitches can appeal to tech-savvy healthcare providers seeking modern respiratory medical devices.

Revenue Range With an estimated revenue between $50M - 100M, Trudell Medical International falls within the mid-range segment in the medical equipment manufacturing industry. Positioning sales strategies to target mid-sized healthcare institutions and providers can capitalize on this revenue bracket.

Strategic Partnerships By partnering with companies like InCarda Therapeutics, Trudell Medical International enhances its market presence and diversifies its offerings. Leveraging these collaborations in sales discussions can demonstrate a comprehensive approach to respiratory healthcare solutions.